History & Overview Annual Report President's Pages Center News Community Affairs

Make a Gift Yankees Universe Fund Fred's Team Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck Cookbook

Press Releases Information for Journalists News@MSKCC

Manhattan New Jersey Long Island Westchester

Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days Job Search & Apply Online

Clinical Trials

Clicking a link below will scroll the
page down to the relevant section

Acute Lymphoblastic Leukemia
Acute Myelocytic Leukemia
Acute Myelogenous Leukemia
Chronic Lymphocytic Leukemia
Chronic Myelocytic Leukemia

Acute Lymphoblastic Leukemia

A Phase I Study of Clofarabine Plus Topotecan, Vinorelbine, Thiotepa, and Dexamethasone in Pediatric Patients with Relapsed or Refractory Acute Leukemia
Steinherz, Peter, MD

[Protocol 07-012]
A Phase I/II Study of Clofarabine in Combination with Etoposide and Cyclophosphamide in Pediatric Patients with Refractory or Relapsed Acute Leukemia
Steinherz, Peter, MD

[Protocol 07-039]
A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adults with Hematological Cancers
Barker, Juliet, MBBS

[Protocol 07-072]
A Phase II Pilot Trial of Hematopoietic Stem Cell Transplantation with Total Body Irradiation, Cyclophosphamide & Fludarabine to Treat Patients with Fanconi Anemia Lacking a Genotypically Identical Donor
Boulad, Farid, MD

[Protocol 01-062]
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Leukemia Following Total Body Irradiation and Stem Cell Transplant
Oeffinger, Kevin, MD

[Protocol 07-092]

Acute Myelocytic Leukemia

A Phase I Study of Clofarabine Plus Topotecan, Vinorelbine, Thiotepa, and Dexamethasone in Pediatric Patients with Relapsed or Refractory Acute Leukemia
Steinherz, Peter, MD

[Protocol 07-012]
A Phase I Study of SGN-33 (Lintuzumab) in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
Jurcic, Joseph, MD

[Protocol 05-132]
A Phase I/II Study of Clofarabine in Combination with Etoposide and Cyclophosphamide in Pediatric Patients with Refractory or Relapsed Acute Leukemia
Steinherz, Peter, MD

[Protocol 07-039]
A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adults with Hematological Cancers
Barker, Juliet, MBBS

[Protocol 07-072]
A Phase II Trial of T Cell Depleted Peripheral Blood Stem Cell Transplantation to Treat Patients with AML in First or Second Complete Remission
O'Reilly, Richard, MD

[Protocol 06-005]

Acute Myelogenous Leukemia

A Phase I/II Study of Clofarabine in Combination with Etoposide and Cyclophosphamide in Pediatric Patients with Refractory or Relapsed Acute Leukemia
Steinherz, Peter, MD

[Protocol 07-039]
A Phase I/II Study to Assess AZD1152 in Patients with Acute Myeloid Leukemia
Berman, Ellin, MD

[Protocol 08-014]
A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adults with Hematological Cancers
Barker, Juliet, MBBS

[Protocol 07-072]
A Phase II Study of Peri-transplant Palifermin followed by an Allogeneic T-Cell-Depleted Stem Cell Transplant in Patients with Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Evolved from MDS
Castro-Malaspina, Hugo, MD

[Protocol 08-008]
A Phase IIB Study of Low-Dose Cytarabine Alone and with Lintuzumab in Patients Age 60 and Older with Previously Untreated AML
Jurcic, Joseph, MD

[Protocol 08-010]
A Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients with Thoracic and Myeloid Neoplasms
Krug, Lee, MD

[Protocol 06-085]
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Leukemia Following Total Body Irradiation and Stem Cell Transplant
Oeffinger, Kevin, MD

[Protocol 07-092]

Chronic Lymphocytic Leukemia

A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with B cell Lymphoid Malignancies
Barker, Juliet, MBBS

[Protocol 06-066]
A Phase I Study of CNF2024 in Patients with B-Cell Chronic Lymphocytic Leukemia (CLL)
Lamanna, Nicole, MD

[Protocol 06-048]
A Phase I Study of Genetically Modified T Cells to Treat Recurrent or Refractory Chronic Lymphocytic Leukemia
Brentjens, Renier, MD, PhD

[Protocol 06-138]
A Phase I-II Study of Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Previously Treated Patients with Chronic Lymphocytic Leukemia and Other Low Grade B-Cell Cancers
Lamanna, Nicole, MD

[Protocol 05-077]
A Phase I/II Study of Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Patients with Relapsed/Refractory Indolent B-cell Lymphoproliferative Disorders and Mantle Cell Lymphoma (MCL)
Gerecitano, John, MD, PhD

[Protocol 05-103]
A Phase II Study of Pentostatin with Cyclophosphamide and Rituximab for Previously Untreated Patients with Chronic Lymphocytic Leukemia
Weiss, Mark, MD

[Protocol 05-051]

Chronic Myelocytic Leukemia

A Phase III Study of Imatinib Versus Nilotinib in Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia in Chronic Phase
Heaney, Mark, MD, PhD

[Protocol 08-033]
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Leukemia Following Total Body Irradiation and Stem Cell Transplant
Oeffinger, Kevin, MD

[Protocol 07-092]
Effect of Imatinib on Bone Metabolism, Lipid Metabolism, and Thyroid Function in Patients with Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors
Berman, Ellin, MD

[Protocol 06-142]

Site Map \| Index	Legal Disclaimer \| Privacy Practices \| Public Notices

©2008 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org